FDA+ channel feed – Endpoints News

FDA+ channel feed

Unlikely duo leads bipartisan Senate bill to expand Right to Try into MDMA and psilocybin

3 years ago

Exclusive: Turnover tsunami at FDA's pharma inspections office puts the backlog in sharp focus

3 years ago

CBO finds Senate's FDA user fee bill will reduce the federal deficit by about $1.4B

3 years ago

Biosimilar inspections still lagging as the FDA looks to clear its backlog

3 years ago

Updated: Spanish heparin manufacturer draws the ire of the FDA in its latest warning over quality concerns

3 years ago

FDA+ roundup: New draft guidance on therapeutic equivalence; Cavazzoni talks accelerated approvals

3 years ago

Without voluntary withdrawals, ODAC to review two more dangling accelerated approvals

3 years ago

MDMA psychotherapy trial put on pause after Health Canada inspection

3 years ago

Incyte nabs second approval with JAK inhibitor cream for vitiligo

3 years ago

Microcap Viking gets a reprieve as FDA lifts hold on PhII study for rare metabolic disorder

3 years ago

Weeks after rare disease drug got spurned, Acer returns to FDA for second shot

3 years ago

Pfizer celebrates a new FDA approval as the Xalkori franchise slowly winds down

3 years ago

Pfizer's Hospira issues a recall for a batch of propofol due to a visible particulate

3 years ago

FDA user fee bill deadline falls apart? Thousands of pink slips for FDA could be coming as Burr seeks to start anew

3 years ago

Drug shortages remain low in 2021 as FDA's prevention efforts grow, report to Congress says

3 years ago

Novartis’ $650M cash bet on a near-term FDA OK for BeiGene’s China PD-1? It just got delayed indefinitely

3 years ago

mRNA alternative: Novavax finally scores EUA for primary Covid-19 vaccine series

3 years ago

FDA again spells out safety concerns with oral type 1 diabetes drug while denying Lexicon's attempt to overturn a CRL

3 years ago

FDA commissioner's vision: Time to revamp the evidence generation system

3 years ago

Following in FDA's footsteps, EMA plots transition to reviewing raw clinical data

3 years ago

Rx-to-OTC switches: What FDA's new proposed rule means for pharma companies

3 years ago

FDA lifts hold on Greenwich LifeSciences as biotech will forge ahead with immunotherapy drug candidate

3 years ago

Congressional reps push FDA to adopt ‘clear, conspicuous and neutral’ rule for pharma drug ads

3 years ago

HRA Pharma seeks approval for first-ever OTC birth control pill in the US

3 years ago

First page Previous page 77 78 798081 82 83 Next page Last page